PhosphoSens AKT3 [G171R] Protein Kinase Assays, Substrates & Recombinant Enzymes

Also known as: AKT3 • AKT Serine/Threonine Kinase 3 • PKBG • PRKBG • STK-2 • RAC-gamma • RAC-PK- gamma

Continuous, real-time assays that directly quantify AKT3 [G171R] catalytic activity — generating a full progress curve in every well for IC₅₀, mechanism, and selectivity studies.

  • Real-time kinetic or TRF endpoint formats
  • Optimized substrates and assay-ready kits
  • Compatible with physiological ATP and cofactors

Designed for: drug discovery, lead optimization, and mechanistic kinase research teams

 

PhosphoSens AKT3 [G171R] kinase assay kit — continuous real-time fluorescence

AKT3 [G171R] at a glance. AKT3 [G171R] activity is measured continuously and directly with the PhosphoSens® AQT0536 substrate, with no antibodies or coupling enzymes.

Substrate
AQT0536
Assay kits
200 or 1,000 assays, from $425

About AKT3 [G171R]

AKT3 (AKT Serine/Threonine Kinase 3, also known as PKBγ) belongs to the AGC kinase superfamily alongside AKT1 and AKT2. All three isoforms share a conserved domain architecture comprising a pleckstrin homology (PH) domain, a kinase domain, and a hydrophobic motif. AKT3 is activated downstream of PI3K via phosphoinositide-dependent kinase-1 (PDK1)-mediated phosphorylation at T305 and mTORC2-mediated phosphorylation at S472. Once active, AKT3 phosphorylates substrates including GSK3β, FOXO transcription factors, TSC2, and BAD, driving cell survival, proliferation, and metabolic reprogramming. AKT3 is predominantly expressed in the brain and is the dominant isoform in melanoma and glioblastoma. PTEN loss, PIK3CA gain-of-function mutations, and AKT3 amplification are frequent oncogenic drivers. The isoform-selective nature of AKT3 in CNS malignancies makes it an attractive target for precision oncology strategies, and understanding isoform-specific kinetics is critical for drug candidate differentiation.

Why PhosphoSens for AKT3 [G171R]?

A principal challenge in AKT3 drug discovery is distinguishing isoform-selective inhibition from pan-AKT activity in biochemical assays. Traditional endpoint methods such as ADP-Glo and HTRF measure single time-point signals that obscure mechanistic details and are highly sensitive to assay timing artifacts and compound interference. Radiometric assays offer sensitivity but introduce radioactive handling burdens and poor throughput. PhosphoSens continuous kinase assays overcome these limitations by generating real-time fluorescent progress curves using a sox-based peptide substrate at physiological ATP concentrations. This enables accurate Km, Vmax, and Ki determination, direct measurement of covalent kinact/KI parameters for irreversible or covalent-warhead inhibitors, and detection of slow-binding kinetics often missed at endpoint. The continuous format is fully compatible with AKT3 isoform selectivity profiling, reducing false positives and delivering mechanistically richer SAR data earlier in the discovery pipeline.

Key Pathways: PI3K/AKT/mTOR signaling PTEN tumor suppressor pathway FOXO transcription factor regulation GSK3 signaling
Approved Inhibitors:
Capivasertib (Truqap, HR+/HER2- breast cancer in combination with fulvestrant)

Talk to a Scientist

Have questions about AKT3 [G171R] assay design, selectivity panels, or covalent inhibitor characterization?

Ask Our Scientists →
How pricing works:
Select a kit or substrate below, then request a quote. Bundle discounts apply automatically.

Real-Time AKT3 [G171R] Activity Assays

Continuous, real-time fluorescent assays optimized for quantitative AKT3 [G171R] activity measurements, IC50 determination, and mechanistic studies.

Assay Format: Continuous kinetic fluorescence (real-time)

PhosphoSens-Kinetic assays directly quantify enzyme activity by continuously monitoring substrate phosphorylation or dephosphorylation in real time, generating a full progress curve in every well.

Learn more about PhosphoSens-Kinetic →

Need pricing or availability? Select a kit or substrate to request a quote below.

Kits

PhosphoSens-Kinetic Kinase Activity Kit - AQT0536

Substrate: AQT0536

Ready-to-use assay kits containing substrate and all essential reagents.

Kit Contents
  • Optimized PhosphoSens® substrate (AQT0536)
  • ATP, DTT, EGTA, Reaction Buffer & Dilution Buffer

Automatically save 10% when bundling 10ug recombinant enzyme with your 1,000 assay kit. View enzymes

Price: $425

Substrate

PhosphoSens Kinase Substrate AQT0536

See every target AQT0536 assays →

Bulk PhosphoSens® substrate for assay development and high-throughput workflows.

Specifications
  • Catalog #: AQT0536
  • Phospho-acceptor: Serine/threonine
  • Validated for: 9 kinases
  • Formats: PhosphoSens-Kinetic

Automatically save 10% when bundling Reagent Packs with your substrate. View Reagent Packs

Price: $2795

One substrate, many targets

AQT0536 also assays 5 other kinases, plus 2 other AKT3 variants

Validated with the same PhosphoSens® substrate, so you can run a selectivity panel in one assay format.

Explore AQT0536 →

Ready to request pricing for AKT3 [G171R]?

Select a kit, substrate, or enzyme above. Our team will confirm pricing, availability, and any applicable bundle discounts.

No PhosphoSens-Red format is currently available for AKT3 [G171R].

Ready to request pricing for AKT3 [G171R]?

Select a kit, substrate, or enzyme above. Our team will confirm pricing, availability, and any applicable bundle discounts.

No recombinant enzymes are currently available for AKT3 [G171R].

🔬 150+ peer-reviewed citations · 🏛️ MIT spinout technology · ⚗️ PhosphoSens® validated by independent labs worldwide · Browse technical articles →

Data & Resources

Explore data and documents to support your kinase and phosphatase experiments. Download sample data, protocols and other resources to see how our assays perform and to help you get started in your own lab. All validation data generated using PhosphoSens® assays under recommended conditions.

Still have questions about our products?

Our scientists can help you choose the right assay format, substrate, and enzyme for your experiment.

Stay Informed

Want to hear the latest about our technology? Be among the first to learn about our latest products and services.

Request a Quote

Cookie Settings / Do Not Sell or Share My Personal Information